{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:24:20Z","timestamp":1780071860066,"version":"3.54.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"scientific research","award":["No. 20K09771"],"award-info":[{"award-number":["No. 20K09771"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We examined the effect of reduced fluence (rf)-photodynamic therapy (PDT) of the macular area on the wide-field choroidal thickness in 20 eyes with central serous chorioretinopathy (CSC) and 20 age- and sex-matched control eyes. The choroidal thickness at the posterior pole was measured before and after rf-PDT, using a grid with inner and outer rings, each divided into superotemporal, inferotemporal, superonasal, and inferonasal quadrants, respectively, making up a total of nine subfields including the central 3\u00a0mm ring. Before treatment, all eyes showed wide-field choroidal thickening from the dilated vortex vein ampulla to the fovea, along the course of the vein. After rf-PDT of the macular area, the choroidal thickness significantly decreased, not only in the irradiated macular area but also outside the arcade vessels in all quadrants (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for all inner subfields; <jats:italic>p<\/jats:italic>\u2009=\u20090.035 and <jats:italic>p<\/jats:italic>\u2009=\u20090.024 for the outer superonasal and inferonasal subfields, respectively; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and <jats:italic>p<\/jats:italic>\u2009=\u20090.004 for the outer superotemporal and inferotemporal subfields, respectively). For control eyes, the choroidal thickness did not differ between the initial visit and follow-up 1.2\u2009\u00b1\u20090.7\u00a0months after the initial visit (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05 for all subfields). These findings provide new insights into the pathogenesis of CSC and explain the reasons for the effectiveness of rf-PDT for this condition.<\/jats:p>","DOI":"10.1038\/s41598-023-37802-w","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:08:26Z","timestamp":1688555306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy"],"prefix":"10.1038","volume":"13","author":[{"given":"Naomi","family":"Nishigori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Ueda-Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"37802_CR1","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/bjophthalmol-2021-319403","volume":"106","author":"A Kido","year":"2022","unstructured":"Kido, A. et al. Incidence of central serous chorioretinopathy (2011\u20132018): A nationwide population-based cohort study of Japan. Br. J. Ophthalmol. 106, 1748\u20131753 (2022).","journal-title":"Br. J. Ophthalmol."},{"key":"37802_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0002-9394(14)73760-2","volume":"120","author":"MR Hee","year":"1995","unstructured":"Hee, M. R. et al. Optical coherence tomography of central serous chorioretinopathy. Am. J. Ophthalmol. 120, 65\u201374 (1995).","journal-title":"Am. J. Ophthalmol."},{"key":"37802_CR3","doi-asserted-by":"publisher","first-page":"e0206646","DOI":"10.1371\/journal.pone.0206646","volume":"13","author":"S Kishi","year":"2018","unstructured":"Kishi, S. et al. Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy. PLoS ONE 13, e0206646 (2018).","journal-title":"PLoS ONE"},{"key":"37802_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/IAE.0b013e3181c72068","volume":"30","author":"A Tsujikawa","year":"2010","unstructured":"Tsujikawa, A. et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina 30, 801\u2013809 (2010).","journal-title":"Retina"},{"key":"37802_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","volume":"146","author":"RF Spaide","year":"2008","unstructured":"Spaide, R. F., Koizumi, H. & Pozzoni, M. C. Enhanced depth imaging spectral-domain optical coherence tomography. Am. J. Ophthalmol. 146, 496\u2013500 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"37802_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura, Y., Fujiwara, T., Margolis, R. & Spaide, R. F. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29, 1469\u20131473 (2009).","journal-title":"Retina"},{"key":"37802_CR7","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.ophtha.2012.02.021","volume":"119","author":"P Jirarattanasopa","year":"2012","unstructured":"Jirarattanasopa, P. et al. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Ophthalmology 119, 1666\u20131678 (2012).","journal-title":"Ophthalmology"},{"key":"37802_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00416865","volume":"192","author":"SS Hayreh","year":"1974","unstructured":"Hayreh, S. S. Submacular choroidal vascular pattern. Experimental fluorescein fundus angiographic studies. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 192, 181\u2013196 (1974).","journal-title":"Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol."},{"key":"37802_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla, D. L. & Wallman, J. The multifunctional choroid. Prog. Retin. Eye Res. 29, 144\u2013168 (2010).","journal-title":"Prog. Retin. Eye Res."},{"key":"37802_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.oret.2017.05.013","volume":"2","author":"T Hiroe","year":"2018","unstructured":"Hiroe, T. & Kishi, S. Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol. Retina 2, 152\u2013161 (2018).","journal-title":"Ophthalmol. Retina"},{"key":"37802_CR11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.oret.2020.03.024","volume":"4","author":"H Matsumoto","year":"2020","unstructured":"Matsumoto, H. et al. Vortex vein anastomosis at the watershed in pachychoroid spectrum diseases. Ophthalmol. Retina 4, 938\u2013945 (2020).","journal-title":"Ophthalmol. Retina"},{"key":"37802_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.oret.2022.04.011","volume":"6","author":"M Ishikura","year":"2022","unstructured":"Ishikura, M. et al. Widefield choroidal thickness of eyes with central serous chorioretinopathy examined by swept-source OCT. Ophthalmol. Retina 6, 949\u2013956 (2022).","journal-title":"Ophthalmol. Retina"},{"key":"37802_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.oret.2020.07.011","volume":"5","author":"N Imanaga","year":"2021","unstructured":"Imanaga, N. et al. Scleral thickness in central serous chorioretinopathy. Ophthalmol. Retina 5, 285\u2013291 (2021).","journal-title":"Ophthalmol. Retina"},{"key":"37802_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ajo.2021.09.009","volume":"235","author":"N Imanaga","year":"2022","unstructured":"Imanaga, N. et al. Clinical factors related to loculation of fluid in central serous chorioretinopathy. Am. J. Ophthalmol. 235, 197\u2013203 (2022).","journal-title":"Am. J. Ophthalmol."},{"key":"37802_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/IAE.0000000000003376","volume":"42","author":"N Terao","year":"2022","unstructured":"Terao, N. et al. Ciliochoroidal effusion in central serous chorioretinopathy. Retina 42, 730\u2013737 (2022).","journal-title":"Retina"},{"key":"37802_CR16","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","volume":"86","author":"RF Spaide","year":"2022","unstructured":"Spaide, R. F. et al. Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. Prog. Retin. Eye Res. 86, 100973 (2022).","journal-title":"Prog. Retin. Eye Res."},{"key":"37802_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","volume":"126","author":"S Mrejen","year":"2019","unstructured":"Mrejen, S. et al. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology 126, 576\u2013588 (2019).","journal-title":"Ophthalmology"},{"key":"37802_CR18","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0002-9394(02)01428-9","volume":"133","author":"A von R\u00fcckmann","year":"2002","unstructured":"von R\u00fcckmann, A., Fitzke, F. W., Fan, J., Halfyard, A. & Bird, A. C. Abnormalities of fundus autofluorescence in central serous retinopathy. Am. J. Ophthalmol. 133, 780\u2013786 (2002).","journal-title":"Am. J. Ophthalmol."},{"key":"37802_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","volume":"58","author":"B Nicholson","year":"2013","unstructured":"Nicholson, B., Noble, J., Forooghian, F. & Meyerle, C. Central serous chorioretinopathy: Update on pathophysiology and treatment. Surv. Ophthalmol. 58, 103\u2013126 (2013).","journal-title":"Surv. Ophthalmol."},{"key":"37802_CR20","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.1016\/j.xops.2022.100152","volume":"2","author":"N Aisu","year":"2022","unstructured":"Aisu, N. et al. Effectiveness of reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmol. Sci. 2, 100152 (2022).","journal-title":"Ophthalmol. Sci."},{"key":"37802_CR21","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","volume":"115","author":"WM Chan","year":"2008","unstructured":"Chan, W. M., Lai, T. Y., Lai, R. Y., Liu, D. T. & Lam, D. S. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: One-year results of a randomized controlled trial. Ophthalmology 115, 1756\u20131765 (2008).","journal-title":"Ophthalmology"},{"key":"37802_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajo.2014.01.022","volume":"157","author":"M Nicolo","year":"2014","unstructured":"Nicolo, M. et al. Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am. J. Ophthalmol. 157, 1033\u20131037 (2014).","journal-title":"Am. J. Ophthalmol."},{"key":"37802_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","volume":"31","author":"JY Shin","year":"2011","unstructured":"Shin, J. Y., Woo, S. J., Yu, H. G. & Park, K. H. Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina 31, 119\u2013126 (2011).","journal-title":"Retina"},{"key":"37802_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"WM Chan","year":"2003","unstructured":"Chan, W. M. et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br. J. Ophthalmol. 87, 1453\u20131458 (2003).","journal-title":"Br. J. Ophthalmol."},{"key":"37802_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/bjophthalmol-2016-308921","volume":"101","author":"T Izumi","year":"2017","unstructured":"Izumi, T. et al. Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy. Br. J. Ophthalmol. 101, 433\u2013437 (2017).","journal-title":"Br. J. Ophthalmol."},{"key":"37802_CR26","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","volume":"117","author":"I Maruko","year":"2010","unstructured":"Maruko, I. et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117, 1792\u20131799 (2010).","journal-title":"Ophthalmology"},{"key":"37802_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/aos.14775","volume":"99","author":"TJ van Rijssen","year":"2021","unstructured":"van Rijssen, T. J. et al. Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser. Acta Ophthalmol. 99, 805\u2013811 (2021).","journal-title":"Acta Ophthalmol."},{"key":"37802_CR28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/archopht.121.7.975","volume":"121","author":"M Tittl","year":"2003","unstructured":"Tittl, M. et al. Topical fundus pulsation measurement in patients with active central serous chorioretinopathy. Arch. Ophthalmol. 121, 975\u2013978 (2003).","journal-title":"Arch. Ophthalmol."},{"key":"37802_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","volume":"122","author":"K Fujita","year":"2015","unstructured":"Fujita, K. et al. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 122, 555\u2013561 (2015).","journal-title":"Ophthalmology"},{"key":"37802_CR30","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/IAE.0b013e31820f4b39","volume":"31","author":"I Maruko","year":"2011","unstructured":"Maruko, I., Iida, T., Sugano, Y., Ojima, A. & Sekiryu, T. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 31, 1603\u20131608 (2011).","journal-title":"Retina"},{"key":"37802_CR31","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1097\/IAE.0b013e31822bf6b1","volume":"31","author":"I Maruko","year":"2011","unstructured":"Maruko, I., Iida, T., Sugano, Y., Furuta, M. & Sekiryu, T. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Retina 31, 1921\u20131927 (2011).","journal-title":"Retina"},{"key":"37802_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10384-013-0230-3","volume":"57","author":"Y Sugano","year":"2013","unstructured":"Sugano, Y., Iida, T., Maruko, I., Ojima, A. & Sekiryu, T. Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy. Jpn. J. Ophthalmol. 57, 294\u2013300 (2013).","journal-title":"Jpn. J. Ophthalmol."},{"key":"37802_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","volume":"240","author":"U Schlotzer-Schrehardt","year":"2002","unstructured":"Schlotzer-Schrehardt, U. et al. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch. Clin. Exp. Ophthalmol. 240, 748\u2013757 (2002).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"37802_CR34","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1167\/iovs.07-0767","volume":"49","author":"M Berdugo","year":"2008","unstructured":"Berdugo, M. et al. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Invest. Ophthalmol. Vis. Sci. 49, 1633\u20131644 (2008).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"37802_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0014-4835(73)90185-1","volume":"15","author":"A Alm","year":"1973","unstructured":"Alm, A. & Bill, A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp. Eye Res. 15, 15\u201329 (1973).","journal-title":"Exp. Eye Res."},{"key":"37802_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00006982-199818010-00006","volume":"18","author":"S Yoneya","year":"1998","unstructured":"Yoneya, S. et al. The improved image of indocyanine green angiography in young healthy volunteers. Retina 18, 30\u201336 (1998).","journal-title":"Retina"},{"key":"37802_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","volume":"16","author":"MB Breukink","year":"2015","unstructured":"Breukink, M. B. et al. Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): Study protocol for a randomized controlled trial. Trials 16, 419 (2015).","journal-title":"Trials"},{"key":"37802_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00175988","volume":"232","author":"AG Bennett","year":"1994","unstructured":"Bennett, A. G., Rudnicka, A. R. & Edgar, D. F. Improvements on Littmann\u2019s method of determining the size of retinal features by fundus photography. Graefes Arch. Clin. Exp. Ophthalmol. 232, 361\u2013367 (1994).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37802-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37802-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37802-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:15:25Z","timestamp":1688555725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37802-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37802"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37802-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10890"}}